SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is surging on massive AI-driven memory demand, with analysts dramatically raising price targets and the stock surpassing $1 trillion in market cap, sparking community discussion about its unstoppable momentum and future potential.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares (SOXS) is trending as investors grapple with extreme volatility and the severe decay inherent in the fund amid an unprecedented, AI-fueled rally in semiconductor stocks. The community is heavily focused on debating whether this represents a sustainable bubble or an inevitable correction, while many retail participants report significant losses from attempting to time the top in a sector characterized by parabolic momentum.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is trending as investors monitor potential breakout signals ahead of upcoming earnings, with active community discussion centering on the company's expanding AI infrastructure footprint in Southeast Asia and the interplay between its high-growth contract pipeline and ongoing capital structure needs. Traders are closely tracking technical levels and potential short squeeze dynamics, contrasting the company's aggressive business development announcements with concerns regarding dilution risks and operational execution.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is seeing intense volatility and significant retail FOMO as community members debate whether the parabolic semiconductor rally is a sustainable growth cycle or an AI-driven bubble reaching a climax. Investors are heavily focused on the disconnect between the fund's rapid price appreciation and broader market indicators, with many traders actively debating the merits of holding through potential geopolitical volatility versus capitalizing on historical gains.

Momentus, Inc. engages in the provision of in-space infrastructure services. It offers space transportation and in-orbit servicing. The company was founded by Mikhail Kokorich in 2017 and is headquartered in Santa Jose, CA.

Momentus Inc - Ordinary Shares - Class A

Momentus Inc. (MNTS) is experiencing significant trading volume and community discussion driven by the anticipation of the SpaceX IPO, with traders eyeing potential short squeezes and sector-wide momentum.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF (SOXX) is experiencing intense market conversation, with discussions highlighting its parabolic rise and potential for extreme volatility, contrasting its theoretical upside with the limited gains of inverse ETFs like SOXS. Traders are debating whether the current surge in SOXX, fueled by AI demand and company-specific catalysts, represents a sustainable rally or an overextended bubble nearing a significant correction.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire Corp (RDW) is experiencing a surge driven by its critical role in NASA's Artemis program and potential for short squeezes, with the community buzzing about its lunar infrastructure technologies like 3D-printed landing pads and in-space manufacturing capabilities.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Community sentiment is divided on Zscaler following recent analyst actions and mixed earnings commentary, with some eyeing potential oversold bounces while others anticipate further downside due to concerns over decelerating growth and increased capital expenditures.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is under intense pressure as investors navigate a public proxy fight between the board and founder Chip Wilson, while also weighing concerns over leadership changes and heightened competition in the athleisure sector. Community sentiment is deeply polarized, with many retail investors viewing the current valuation as a contrarian buying opportunity despite ongoing technical weakness.

Sidus Space, Inc. is a space-as-a-service company. The firm focuses on commercial satellite design, manufacture, launch planning, mission operations and in-orbit support, and data collection with a vision to demonstrate space operations for new technologies, and deliver data and predictive analytics to both domestic and global customers. The company was founded by Carol M. Craig on July 17, 2012 and is headquartered in Merritt Island, FL.

Sidus Space Inc - Ordinary Shares - Class A

The space sector is experiencing a significant surge in interest, with $SIDU showing strong momentum as investors anticipate the SpaceX IPO and potential defense contracts, sparking discussions about short squeezes and sector rotation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Entrada Therapeutics, Inc. - TRDA

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Entrada Therapeutics, Inc. - TRDA INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Entrada Therapeutics, Inc. - TRDA PR Newswire NEW YORK, May 14, 2026 NEW YORK, May 14, 2026...

Entrada Therapeutics Clinical Trial Data Sparks Brutal Stock Selloff - Here's Why

Entrada Therapeutics stock plunged after the Duchenne trial data missed investor expectations despite positive functional improvement signals.read more...

Entrada Therapeutics, Inc. (TRDA) Reports Q1 Loss, Misses Revenue Estimates

Entrada Therapeutics (TRDA) delivered earnings and revenue surprises of +10.59% and -86.24%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Entrada Therapeutics (TRDA) Surges 8.9%: Is This an Indication of Further Gains?

Entrada Therapeutics (TRDA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Entrada Therapeutics (NASDAQ:TRDA) Insider Sells $398,708.73 in Stock

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) insider Natarajan Sethuraman sold 25,907 shares of the company's stock in a transaction dated Monday, May 4th. The stock was sold at an average price of $15.39, for a total value of $398,708.73. Following the transaction, the insider...

Entrada Therapeutics (NASDAQ:TRDA) COO Nathan Dowden Sells 15,000 Shares

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) COO Nathan Dowden sold 15,000 shares of the firm's stock in a transaction dated Monday, May 4th. The shares were sold at an average price of $15.33, for a total transaction of $229,950.00. Following the transaction, the chief operating...

Travere Therapeutics (TVTX) Reports Q1 Loss, Misses Revenue Estimates

Travere (TVTX) delivered earnings and revenue surprises of -30.74% and -1.84%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Entrada Therapeutics (NASDAQ:TRDA) Trading 7.6% Higher - Should You Buy?

Entrada Therapeutics (NASDAQ:TRDA) Stock Price Up 7.6% - What's Next...

Entrada Therapeutics (NASDAQ:TRDA) Reaches New 12-Month High  - What's Next?

Entrada Therapeutics (NASDAQ:TRDA) Hits New 52-Week High - Here's What Happened...

Entrada Therapeutics (TRDA) Expected to Announce Earnings on Thursday

Entrada Therapeutics (NASDAQ:TRDA) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-entrada-therapeutics-inc-stock...

Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company’s Endosomal Escape Vehicle (EEV) therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Through this proprietary, versatile and modular approach, Entrada is advancing a robust development portfolio of RNA- and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. The company’s oligonucleotide programs are in development for the potential treatment of people living with Duchenne who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1. Entrada Therapeutics was founded by Dehua Pei in 2016 and is headquartered in Boston, MA.

Current Price	$6.70
Prev Close	$6.56
Open	$6.61
Dividend Yield	0.00%
50-Day Moving Average	$11.49
Beta	1.54
Avg. Volume	170,933.70
PE Ratio	-1.68

52-Week High	$16.45
52-Week Low	$4.93
Market Capitalization	$260.1M
EPS (Annual)	-$3.47
Price to Book	0.96
Revenue Per Employee	$167,243.42

TRDA
Entrada Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest TRDA News

TRDAEntrada Therapeutics Inc